Scleromyxedema: A potentially disabling and fatal disease

F. Rongioletti

Research output: Contribution to journalArticle


Scleromyxedema (SCL), considered to be the generalized and sclerodermoid subtype of lichen myxedematosus (papular mucinosis), is a disease with a chronic, progressive, and potentially disabling course. It is usually, although not invariably, associated with a monoclonal gammopathy which rarely leads to multiple myeloma and with many systemic manifestations. The therapy is difficult and the prognosis is guarded. The author, on the basis of literature and personal experience, review the anatomo-clinical manifestations of this uncommon disease.

Original languageEnglish
Pages (from-to)323-328
Number of pages6
JournalGiornale Italiano di Dermatologia e Venereologia
Issue number3
Publication statusPublished - 2000


  • Mucinoses
  • Scleromyxedema
  • Skin diseases

ASJC Scopus subject areas

  • Dermatology

Fingerprint Dive into the research topics of 'Scleromyxedema: A potentially disabling and fatal disease'. Together they form a unique fingerprint.

Cite this